Possible conglomerate effects arise because of the complementarity of the Parties’
product portfolios and the Parties’ significant market position in certain product markets, for example lactase. The Commission considered both technical and commercial bundling possibilities of dairy enzymes with each other and dairy enzymes with dairy cultures and investigated whether such bundling strategies would allow the Parties to foreclose other players in the market, for example other manufacturers of dairy enzymes and dairy cultures.